BACKGROUND: Subjects with autism suffer from impairments of social interaction, deviations in language usage, as well as restricted and stereotyped patterns of behavior. These characteristics are found irrespective of age, IQ, and gender of affected subjects. However, brain changes due to age, IQ, and gender might pose potential confounds in autism neuroimaging analyses. METHODS: To investigate gray matter differences in autism that are not related to these potential confounds, we performed a voxel-based morphometry analysis in 52 affected children and adolescents and 52 matched control subjects. RESULTS: We observed diminished gray matter in a region of the hypothalamus, which synthesizes the behaviorally relevant hormones oxytocin and arginine vasopressin. CONCLUSIONS: This finding provides support for further investigations of the theory of abnormal functioning of this hormonal system in autism and potentially for experimental therapeutic approaches with oxytocin and related neuropeptides.
BACKGROUND: Subjects with autism suffer from impairments of social interaction, deviations in language usage, as well as restricted and stereotyped patterns of behavior. These characteristics are found irrespective of age, IQ, and gender of affected subjects. However, brain changes due to age, IQ, and gender might pose potential confounds in autism neuroimaging analyses. METHODS: To investigate gray matter differences in autism that are not related to these potential confounds, we performed a voxel-based morphometry analysis in 52 affected children and adolescents and 52 matched control subjects. RESULTS: We observed diminished gray matter in a region of the hypothalamus, which synthesizes the behaviorally relevant hormones oxytocin and arginine vasopressin. CONCLUSIONS: This finding provides support for further investigations of the theory of abnormal functioning of this hormonal system in autism and potentially for experimental therapeutic approaches with oxytocin and related neuropeptides.
Authors: J N Giedd; J Blumenthal; N O Jeffries; F X Castellanos; H Liu; A Zijdenbos; T Paus; A C Evans; J L Rapoport Journal: Nat Neurosci Date: 1999-10 Impact factor: 24.884
Authors: Adam J Guastella; Amanda R Kenyon; Gail A Alvares; Dean S Carson; Ian B Hickie Journal: Biol Psychiatry Date: 2010-05-05 Impact factor: 13.382
Authors: Suma Jacob; Camille W Brune; C S Carter; Bennett L Leventhal; Catherine Lord; Edwin H Cook Journal: Neurosci Lett Date: 2007-02-03 Impact factor: 3.046
Authors: Gregor Domes; Markus Heinrichs; Andre Michel; Christoph Berger; Sabine C Herpertz Journal: Biol Psychiatry Date: 2006-11-29 Impact factor: 13.382
Authors: Adam J Guastella; Stewart L Einfeld; Kylie M Gray; Nicole J Rinehart; Bruce J Tonge; Timothy J Lambert; Ian B Hickie Journal: Biol Psychiatry Date: 2009-11-07 Impact factor: 13.382
Authors: Zening Fu; Yiheng Tu; Xin Di; Yuhui Du; Jing Sui; Bharat B Biswal; Zhiguo Zhang; N de Lacy; V D Calhoun Journal: Neuroimage Date: 2018-06-06 Impact factor: 6.556
Authors: J Ellegood; E Anagnostou; B A Babineau; J N Crawley; L Lin; M Genestine; E DiCicco-Bloom; J K Y Lai; J A Foster; O Peñagarikano; D H Geschwind; L K Pacey; D R Hampson; C L Laliberté; A A Mills; E Tam; L R Osborne; M Kouser; F Espinosa-Becerra; Z Xuan; C M Powell; A Raznahan; D M Robins; N Nakai; J Nakatani; T Takumi; M C van Eede; T M Kerr; C Muller; R D Blakely; J Veenstra-VanderWeele; R M Henkelman; J P Lerch Journal: Mol Psychiatry Date: 2014-09-09 Impact factor: 15.992
Authors: A Kathuria; P Nowosiad; R Jagasia; S Aigner; R D Taylor; L C Andreae; N J F Gatford; W Lucchesi; D P Srivastava; J Price Journal: Mol Psychiatry Date: 2017-09-26 Impact factor: 15.992
Authors: Jordan M Ramsey; Paul C Guest; Jantine Ac Broek; Jeffrey C Glennon; Nanda Rommelse; Barbara Franke; Hassan Rahmoune; Jan K Buitelaar; Sabine Bahn Journal: Mol Autism Date: 2013-08-06 Impact factor: 7.509